Search

everythinglearnresearchcommunity

for

Search:↓

Premature graying of hair may suggest health issues and currently lacks effective treatments.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Understanding how melanocyte stem cells work could lead to new treatments for hair graying and skin pigmentation disorders.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

Facial plastic surgery has evolved to focus on less invasive techniques and innovative technologies for cosmetic and reconstructive procedures.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

Most Korean systemic lupus erythematosus patients experienced hair loss, often as non-scarring diffuse hair loss, with non-scarring patch alopecia also common.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Some medications might reverse gray hair, especially those that reduce inflammation or stimulate pigment production, and vitamin B might help.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

The long-pulsed alexandrite laser is effective for hair reduction, particularly for light-skinned individuals with dark hair, but caution is needed for darker skin.

Hair restoration surgery can have complications; success depends on patient education, careful planning, and proper execution.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Consider benefits and risks of new alopecia treatments for safety.

Topical contact sensitizers can treat certain skin conditions but are rarely used in the U.K.

Treatment can improve survival and symptoms in dogs with Cushing's disease, but outcomes are unpredictable.

New acne treatments show promise as alternatives to traditional therapies.

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.

EPR spectroscopy showed that spontaneous hair growth results in thicker skin and less pigmented hair than depilation-induced growth.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.